Dr. Jack West reviews the IMpower132 trial of platinum + pemetrexed with or without atezolizumab as first line treatment for advanced non-squamous NSCLC and where these results fit into management of patients in this setting.
The IMpower132 Trial: Does This Change the Advanced NSCLC Landscape? (BMIC-069)
By Editor